President and CEO Robert J. Beall, Ph.D., reflects on what this important milestone means for ongoing efforts to speed the development of more therapies for all people with CF.
After experiencing dramatic health improvements while participating in a Kalydeco™ clinical trial, Roe Van Epps, 41, is adjusting to a new world of long-term planning and unexplored life choices.
Cystic fibrosis patients and their families are invited to take advantage of two new resources offered by the CF Foundation.
Don't Miss...
Join us for Great Strides, the Cystic Fibrosis Foundation's largest national fundraising event. Tens of thousands of friends and family come together each year for one cause…to help find a cure for CF.
